Communicating with HCPs through AI; ASCO 2025 highlights; The impact of US tariffs on pharma manufacturing
Rising to meet the challenges of clinical trials; Accelerating access to rare disease treatments; Maximising the potential of AI in pharma
How HCPs and patients are partnering to transform care; The impact of MS on ageing patients; AI in healthcare
PMLiVE’s Top Pharma List is live!; Omnichannel – breaking down the barriers; Rare diseases – improving patient access
Achieving inclusivity for minorities in clinical trials; Why local knowledge is key for pharmacovigilance; EU vs US trends in clinical trials
Avalere Health’s Amar Urhekar on his career path; Insights from ASH 2024; The science behind gene-silencing technology
Sanofi’s John Forni on the escalating challenges of treating COPD; The need for a human touch in an AI world; PMGroup celebrates the 24th PMEAs!
The explosive growth of Gen AI; Liberating patient pathways; Closing health equity gaps
Boehringer Ingelheim’s Ulrike Graefe-Mody on her career path; Driving launch excellence; Top trends coming out of ESMO 2024
The challenges of environmental sustainability; ‘Causes That Count, Health’ report; Rethinking neurodegeneration
Merck’s Doina Ionescu on her professional journey; Full coverage of Communiqué 2024; Omnichannel opportunities
GSK’s Jack Harris on innovation in oncology; Harnessing creativity in a digital age; Sustainability in pharma
Interview with Ipsen’s Ioana Parsons on her new role; Celebrating comms excellence; Getting trial diversity right
Astellas' Marci English on managing the menopause; Clinigen’s Lorna Pender on treating rare diseases; the science behind behaviour change
Interview with Sanofi’s Rippon Ubhi on her new role; Optimising MS care and patient outcomes; Overcoming pharma web strategy challenges
Diversity, equity and inclusion in medical research; Marking International Day of Women and Girls in Science; Incentivising innovation in antibiotics
Interview with AstraZeneca’s Ed Piper on patient outcomes; Pharma trends and predictions for 2024; Precision medicine in chronic diseases
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 18 June 2025
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 21 May 2025
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 10 April 2025
What value does your strategic planning add?
Thought Leadership, 18 March 2025
CAR-Ts pose a unique challenge for healthcare systems, exacerbated by uncertainty around their long-term, real-world value
Thought Leadership, 18 March 2025
Roche and Ascidian agree to $1.8bn neurological disease partnership
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Collecting the right data in the right way for the right reasons
The evolutionary lessons for Bayer’s management restructure
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
Researchers identify new major cause of inflammatory bowel disease
How much time do you spend thinking about the impact of what is working and what is not in today’s organisational reality, versus what was captured in the situational analysis in your brand plan?
Collecting the right data in the right way for the right reasons
The evolutionary lessons for Bayer’s management restructure
UCB’s Bimzelx approved by MHRA for hidradenitis suppurativa
Researchers identify new major cause of inflammatory bowel disease
Roche and Ascidian agree to $1.8bn neurological disease partnership
Roche and Ascidian agree to $1.8bn neurological disease partnership
Researchers identify new major cause of inflammatory bowel disease
Across almost every sector, brands are multiplying their investment in creativity
Features, 18 June 2025
Picking your omnichannel direction requires a disciplined, scientific approach
Features, 18 June 2025
Across almost every sector, brands are multiplying their investment in creativity
Features, 21 May 2025
Picking your omnichannel direction requires a disciplined, scientific approach
Features, 21 May 2025
Across almost every sector, brands are multiplying their investment in creativity
Features, 10 April 2025
Picking your omnichannel direction requires a disciplined, scientific approach
Features, 10 April 2025
Pharmaceutical industry news, articles, jobs, reports, advice and services
